Total Payments
$18,622
2021 Payments
$9,870
Companies
2
Transactions
17
Payment Breakdown by Category
Other$15,000 (80.6%)
Travel$3,622 (19.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,000 | 16 | 80.6% |
| Travel and Lodging | $3,622 | 1 | 19.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Global Blood Therapeutics, Inc. | $15,000 | 16 | $0 (2021) |
| Pierre Fabre Pharmaceuticals, Inc. | $3,622 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $9,870 | 8 | Global Blood Therapeutics, Inc. ($9,870) |
| 2020 | $5,130 | 8 | Global Blood Therapeutics, Inc. ($5,130) |
| 2018 | $3,622 | 1 | Pierre Fabre Pharmaceuticals, Inc. ($3,622) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/28/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $470.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 04/07/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 03/08/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,055.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 02/23/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 02/17/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $705.00 | General |
| 02/16/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $470.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 02/13/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,350.00 | General |
| 01/19/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 11/12/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $195.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 10/29/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $635.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 10/21/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $635.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 08/31/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $635.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/29/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $635.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/23/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $635.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/09/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $480.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/06/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,280.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 05/31/2018 | Pierre Fabre Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $3,621.61 | General |
About Dr. Stephen Nelson, MD
Dr. Stephen Nelson, MD is a Pediatric Hematology-Oncology healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306810577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Nelson, MD has received a total of $18,622 in payments from pharmaceutical and medical device companies, with $9,870 received in 2021. These payments were reported across 17 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,000).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Minneapolis, MN
- Active Since 02/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1306810577
Products in Payments
- OXBRYTA (Drug) $11,945
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Minneapolis
Dr. Margaret Macmillan, Md, MD
Pediatric Hematology-Oncology — Payments: $113,464
Pediatric Hematology-Oncology $113,464
Troy Lund, Md, MD
Pediatric Hematology-Oncology — Payments: $106,257
Pediatric Hematology-Oncology $106,257
Paul Orchard, Md, MD
Pediatric Hematology-Oncology — Payments: $88,393
Pediatric Hematology-Oncology $88,393
Dr. Stephanie Fritch Lilla, Md, MD
Pediatric Hematology-Oncology — Payments: $47,602
Pediatric Hematology-Oncology $47,602
Christopher Moertel, Md, MD
Pediatric Hematology-Oncology — Payments: $33,639
Pediatric Hematology-Oncology $33,639
Christen Ebens, M.d, M.D
Pediatric Hematology-Oncology — Payments: $6,015
Pediatric Hematology-Oncology $6,015